Top news of the week: 01.04.2021.
Startups
Flagship hires Merck veteran to lead AI drug discovery startup
Flagship Pioneering has named Michael Nally as CEO-partner. The venture capital shop has put the former Merck executive in charge of machine-learning-enabled drug discovery play Generate ...
5 FDA approval decisions to watch in the second quarter
A long-awaited reckoning for Biogen’s Alzheimer’s drug and the review of AstraZeneca’s coronavirus vaccine are among the top FDA decisions expected before the end of June.
FACT SHEET: The American Jobs Plan
While the American Rescue Plan is changing the course of the pandemic and delivering relief for working families, this is no time to build back to the way things were. This is the moment to ...
After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B
It’s been a nice month for Pyxis Oncology: After penning a major licensing deal with Pfizer, the startup now has $152 million extra in the bank to help it push on with its expanded pipeline.
How Kendall Square became Boston’s biotech hub
Learn how Kendall Square in Cambridge transformed from an industrial zone to Boston's booming biotechnology and research hub.
British T-cell cancer biotech Achilles Therapeutics guns for $176M IPO
Achilles Therapeutics is looking for a meaty $176 million initial public offering for its next-gen immuno-oncology work.
Former Senior Merck Executive Hired by Life-Sciences Firm
Michael Nally was named a partner at Flagship Pioneering and will become CEO of a startup that leverages machine-learning to develop biotechnology drugs.
Meet 2021's $200K Challenge Finalists
15 Finalists, 15 innovative solutions—Who will win? Join us — REGISTRATION IS FREE!